These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29615269)

  • 1. The public health value of vaccination for seniors in Europe.
    Esposito S; Franco E; Gavazzi G; de Miguel AG; Hardt R; Kassianos G; Bertrand I; Levant MC; Soubeyrand B; López Trigo JA
    Vaccine; 2018 May; 36(19):2523-2528. PubMed ID: 29615269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability.
    La EM; Trantham L; Kurosky SK; Odom D; Aris E; Hogea C
    Hum Vaccin Immunother; 2018 Feb; 14(2):430-441. PubMed ID: 29194019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013.
    McLaughlin JM; McGinnis JJ; Tan L; Mercatante A; Fortuna J
    J Prim Prev; 2015 Aug; 36(4):259-73. PubMed ID: 26032932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older.
    Lehmann BA; Eilers R; Mollema L; Ferreira J; de Melker HE
    BMC Geriatr; 2017 Jun; 17(1):122. PubMed ID: 28592229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to get vaccinated against influenza, pneumococcal disease, pertussis, and herpes zoster - A pre-COVID-19 exploration among the older adult population.
    Maertzdorf KM; Rietman ML; Lambooij MS; Verschuren WMM; Picavet HSJ
    Vaccine; 2023 Feb; 41(6):1254-1264. PubMed ID: 36639273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of increasing vaccination in high-risk adults aged 18-64 Years: a model-based decision analysis.
    Wateska AR; Nowalk MP; Zimmerman RK; Smith KJ; Lin CJ
    BMC Infect Dis; 2018 Jan; 18(1):52. PubMed ID: 29370768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quality improvement initiative to increase Tdap (tetanus, diphtheria, acellular pertussis) vaccination coverage among direct health care providers at a children's hospital.
    Jiang C; Whitmore-Sisco L; Gaur AH; Adderson EE;
    Vaccine; 2018 Jan; 36(2):214-219. PubMed ID: 29217370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
    Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
    Weston WM; Friedland LR; Wu X; Howe B
    Vaccine; 2012 Feb; 30(9):1721-8. PubMed ID: 22212127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
    Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
    Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A formative research-guided educational intervention to improve the knowledge and attitudes of seniors towards influenza and pneumococcal vaccinations.
    Ho HJ; Chan YY; Ibrahim MAB; Wagle AA; Wong CM; Chow A
    Vaccine; 2017 Nov; 35(47):6367-6374. PubMed ID: 29031694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of Vaccine-Preventable Diseases-Measles, Tetanus, Diphtheria and Whooping Cough-in Iran: Findings from the GBD study 2010.
    Mokhayeri Y; Naderimagham S; Mohammadi R; Rahimi E; Rahimzadeh S; Badirzadeh A; Saeedi Moghaddam S; Chegini M; Kompani F; Hashemi-Nazari SS
    Arch Iran Med; 2016 Jun; 19(6):382-7. PubMed ID: 27293052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
    Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Bridges CB;
    MMWR Surveill Summ; 2016 Feb; 65(1):1-36. PubMed ID: 26844596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.
    Scott LJ
    BioDrugs; 2010 Dec; 24(6):387-406. PubMed ID: 21043546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of diseases from Europe through use of vaccines.
    Bytchenko BD; Dittmann S
    Dev Biol Stand; 1986; 65():3-11. PubMed ID: 3556775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Four years of experience with diphtheria-pertussis-tetanus vaccination: 1000 cases].
    MAZA PEREZ C
    Rev Cubana Pediatr; 1954 Aug; 26(8):531-8. PubMed ID: 13224977
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influenza, tetanus, and pertussis vaccination coverage among adults in Germany].
    Bödeker B; Remschmidt C; Müters S; Wichmann O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Feb; 58(2):174-81. PubMed ID: 25446313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Practical aspects of vaccination in elderly subjects].
    de Wazières B
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Sep; 9(3):255-8. PubMed ID: 21896428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of a practice-based intervention to improve vaccination rates in adults less than 65-years-old.
    Smith KJ; Nowalk MP; Lin CJ; Zimmerman RK
    Hum Vaccin Immunother; 2017 Oct; 13(10):2207-2212. PubMed ID: 28829719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of four vaccine preventable diseases in older adults.
    Kristensen M; van Lier A; Eilers R; McDonald SA; Opstelten W; van der Maas N; van der Hoek W; Kretzschmar ME; Nielen MM; de Melker HE
    Vaccine; 2016 Feb; 34(7):942-9. PubMed ID: 26752065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.